- Home
- CNTY vs NTRB Comparison
CNTY vs NTRB Comparison
Compare CNTY & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTY | NTRB |
|---|---|---|
| Founded | 1992 | 2016 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Hotels/Resorts | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.8M | 36.0M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTY | NTRB |
|---|---|---|
| Price | $1.18 | $3.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 56.1K | 9.5K |
| Earning Date | 05-08-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $430,529,000.00 | N/A |
| Revenue This Year | $7.17 | $30.17 |
| Revenue Next Year | $3.28 | $3,394.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.82 | N/A |
| 52 Week Low | $1.14 | $2.90 |
| 52 Week High | $2.85 | $8.63 |
Technical Indicators
Market Signals| Indicator | CNTY | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 40.51 |
| Support Level | $1.14 | $2.91 |
| Resistance Level | $1.47 | $3.67 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 15.79 | 13.16 |
Price Performance
Historical ComparisonAbout CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.